Consumer Health Contract Manufacturing Market Size, Share & Trends Analysis Report By Product (Over-the-counter Drugs, Nutritional Supplements, Personal Care Products, Medical Devices), By Service, By End-use, By Region, And Segment Forecasts, 2025 - 2030

Consumer Health Contract Manufacturing Market Growth & Trends

The global consumer health contract manufacturing market size is expected to reach USD 209.22 billion by 2030, growing at a CAGR of 8.72% from 2025 to 2030, according to a new report by Grand View Research, Inc. Currently, most of the pharmaceutical & biopharmaceutical, nutraceutical, cosmeceutical, and medical device companies prioritize efficiency and cost-effective solution to enhance profitability; hence, outsourcing manufacturing has become essential for cost optimization, regulatory compliance, and improved production capabilities. Moreover, several benefits are offered to healthcare companies, such as the ability to utilize contract manufacturing (CMO) facilities to streamline production and the opportunity to focus on core competencies and drive market growth. Besides, the rising requirement for clean-label formulations and consumers' increasing interest in functional supplements drive innovation in nutraceutical and OTC drug manufacturing.

In addition, shifting consumer preferences toward self-care is one of the significant factors for the rising demand for consumer health products that have fueled the demand for consumer health contract manufacturing. Besides, the market is experiencing rapid expansion driven by rising demand for OTC drugs, dietary supplements, cosmeceuticals, and medical devices. In addition, the rising e-commerce and distribution platforms have led to an increasing need for scalable and flexible manufacturing solutions. Furthermore, stringent regulations from bodies like the FDA, EMA, and GMP have led manufacturers to implement advanced quality control measures, serialization, and compliance-driven production.

Furthermore, the incorporation of advanced technologies, including AI-driven automation, real-time production monitoring, and blockchain-based traceability, is strengthening supply chain efficiency in manufacturing. Contract manufacturing organizations (CMOs) increasingly adopt advanced technologies such as continuous manufacturing, automation, and AI-powered process optimization to advance pharmaceutical production. These technological integrations enhance efficiency, reduce waste, and improve product quality and regulatory compliance.

Likewise, strategic initiatives and accelerating product launches drive the market. For instance, in August 2024, Aenova announced the development of a new gummy production line at its Romania facility. With the rising popularity of gummies as a preferred dosage form for food supplements and pharmaceuticals, the company plans to launch the line by the end of 2024. The new line is projected to have an annual production capacity of approximately one billion gummies. Such initiatives are expected to drive the market over the estimated time period.

Consumer Health Contract Manufacturing Market Report Highlights

• Based on product, the over-the-counter (OTC) drugs segment dominated the market, with a share of 33.25% in 2024. This growth is driven by increased OTC drug production, rising self-medication trends, growing healthcare awareness, expanding e-commerce channels, and growing launches of OTC drugs in the market
• Based on service, the API manufacturing segment held the largest market share in 2024, attributed to the increasing requirements demand for OTC drugs. Besides, innovations in drug development have increased the need for contract manufacturing organizations (CMOs) for their efficiency, scalability, and adherence to regulatory standards, further fueling market expansion
• Based on end-use, the pharmaceutical & biopharmaceutical companies segment held the largest market share in 2024. These companies utilize CMO services to reduce production costs, enhance scalability, and accelerate product time-to-market. CMOs offer specialized manufacturing expertise for comprehensive product development. Outsourcing manufacturing services further provides access to innovative technologies, adaptable production capabilities, and optimized global supply chain management
• Asia Pacific is expected to register the fastest growth rate of 9.48% CAGR over the forecast period due to the rising number of healthcare companies and contract manufacturing organizations(CMOs) in countries such as Japan, China, and India. In addition, the availability of a skilled workforce at comparatively lower costs than in the U.S. is expected to significantly contribute to the market's expansion in this region